Healthcare Economics & Policy

The promised, less expensive insulin product from pharmaceutical company Eli Lilly has officially come to market, the company announced May 22.

Political unrest isn’t taking much of a toll on deals in healthcare, with executives still bullish on the sector, according to new data from Merrill Corp.

Together, private health insurance, Medicare and Medicaid accounted for 82% of total prescription drug spending in the U.S. in 2017, according to a recent analysis from the Kaiser Family Foundation that broke down drug spending that year.

Consumer goods giant Nestlé is in talks to sell its skin health business to private equity firm EQT and the Abu Dhabi Investment Authority for $10.1 billion, The Wall Street Journal reported.

National health spending reached $3.76 trillion in March 2019, a 4.6% jump from the same month in 2018, according to recent data from Altarum, underscoring signs of acceleration during the first quarter of 2019.

JPMorgan Chase has acquired InstaMed, a technology company with a focus in healthcare payments, for a purchase price of more than $500 million.

CMS finalized a rule that aims to boost transparency of the cost of prescription drugs in Medicare Part D and enable Medicare Advantage plans to negotiate better prices for medicines. Notably, the final version backs off a controversial proposal that would have allowed Medicare Part D plans to exclude certain drugs if prices rise beyond a threshold.


Physicians are bringing in more revenue at hospitals in 2019 than previously, according to a recent report from Merritt Hawkins.

Rural hospitals are closing at a quick pace, leaving communities at a loss after sometimes long-standing institutions shutter their doors. In Fort Scott, Kan., the closure of a 132-year-old hospital had to be reckoned with, and the closure brings up the question of if small towns need a traditional hospital at all, NPR reported.

The next step in the ongoing saga of the $69 billion merger between CVS Health and Aetna is scheduled for June 4. That’s when a hearing is set in the U.S. District Court for the District of Columbia, where six witnesses made up of industry stakeholders will testify as U.S. District Judge Richard Leon will decide whether the deal can be finalized.

Forty-four U.S. states have joined together in a lawsuit against 20 drug manufacturers, accusing them of scheme to inflate drug prices and eliminate competition in the market, Reuters reported. The drugmakers are accused of jacking up the prices by more than 1,000% in some cases.

With high compensation and a good work-life balance, Minnesota is the best state for physicians to thrive in 2019, according to a recent ranking from Medscape.